Thymopentin enhances the generation of T-cell lineage derived from human embryonic stem cells in vitro

Experimental Cell Research

Volumn 331, Issue 2, 2015, Pages 387-398

  Zhu, Ming Xia ^a   Wan, Wen Li ^a   Li, Hai Shen ^a   Wang, Jing ^a   Chen, Gui An ^a   Ke, Xiao Yan ^a  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

Cell differentiation; Hematopoietic progenitor cells; Human embryonic stem cells ; T lymphocytes; Thymopentin

Indexed keywords

CD27 ANTIGEN; CD3 ANTIGEN; CD34 ANTIGEN; CD4 ANTIGEN; CD45RA ANTIGEN; CD5 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; COLLAGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR GAMMA DELTA CHAIN; THYMOPENTIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CD45 ANTIGEN; IL2 PROTEIN, HUMAN; MEMBRANE ANTIGEN;

ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL LINEAGE; CLONOGENIC ASSAY; CONTROLLED STUDY; CYTOKINE RESPONSE; DNTT GENE; DRUG EFFECT; DRUG MECHANISM; EMBRYONIC STEM CELL; ERYTHROID CELL; GENE; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IKAROS GENE; IN VITRO STUDY; LYMPHOCYTE FUNCTION; LYMPHOID CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TCRBETA GENE; TCRGAMMA GENE; BIOSYNTHESIS; CYTOLOGY; DRUG EFFECTS; LYMPHOPOIESIS; METABOLISM; PLURIPOTENT STEM CELL;

ANTIGENS, CD34; ANTIGENS, CD45; ANTIGENS, CD7; ANTIGENS, SURFACE; CELL LINEAGE; CELLS, CULTURED; EMBRYONIC STEM CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-2; LYMPHOPOIESIS; PLURIPOTENT STEM CELLS; T-LYMPHOCYTES; THYMOPENTIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84922116237     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2014.12.012     Document Type: Article

References (35)

1. Galic Z., Kitchen S.G., Subramanian A., Bristol G., Marsden M.D., Balamurugan A., Kacena A., Yang O., Zack J.A. Generation of T lineage cells from human embryonic stem cells in a feeder free system. Stem Cells 2009, 27:100-107.
2. Drukker M., Katchman H., Katz G., Even-Tov Friedman S., Shezen E., Hornstein E., Mandelboim O., Reisner Y., Benvenisty N. Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells 2006, 24:221-229.
3. Galic Z., Kitchen S.G., Kacena A., Subramanian A., Burke B., Cortado R., Zack J.A. T lineage differentiation from human embryonic stem cells. Proc. Natl. Acad. Sci. USA 2006, 103:11742-11747.
4. Timmermans F., Velghe I., Vanwalleghem L., De Smedt M., Van Coppernolle S., Taghon T., Moore H.D., Leclercq G., Langerak A.W., Kerre T., Plum J., Vandekerckhove B. Generation of T cells from human embryonic stem cell-derived hematopoietic zones. J. Immunol. 2009, 82:6879-6888.
5. Haddad R., Guardiola P., Izac B., Thibault C., Radich J., Delezoide A.L., Baillou C., Lemoine F.M., Gluckman J.C., Pflumio F., Canque B. Molecular characterization of early human T/NK and B-lymphoid progenitor cells in umbilical cord blood. Blood 2004, 104:3918-3926.
6. + cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood 2005, 105:617-626.
7. Larbi A., Mitjavila-Garcia M.T., Flamant S., Valogne Y., Clay D., Usunier B., l'Homme B., Feraud O., Casal I., Gobbo E., Divers D., Chapel A., Turhan A.G., Bennaceur-Griscelli A., Haddad R. Generation of multipotent early lymphoid progenitors from human embryonic stem cells. Stem Cells Dev. 2014, 23:2983-2995.
8. Goldstein A.L., Low T.L., McAdoo M., McClure J., Thurman G.B., Rossio J., Lai C.Y., Chang D., Wang S.S., Harvey C., Ramel A.H., Meienhofer J. Thymosin alpha1: isolation and sequence analysis of an immunologically active thymic polypeptide. Proc. Natl. Acad. Sci. USA 1977, 74:725-729.
9. Goldstein A.L., Badamchian M. Thymosins: chemistry and biological properties in health and diseases. Expert Opin. Biol. Ther. 2004, 4:559-573.
10. Peng H., Chen G. Serum-free medium cultivation to improve efficacy in establishment of human embryonic stem cell lines. Hum. Reprod. 2006, 21:217-222.
11. Zhu M.X., Wang J., Ke X.Y. Effects of different extracellular matrix on differentiation of human embryonic stem cells into hematopoietic progenitor cells. J. Exp. Hematol. 2014, 22:148-153.
12. Vodyanik M.A., Thomson J.A., Slukvin I.I. Leukosialin (CD43) defines hematopoietic progenitors in human embryonic stem cell differentiation cultures. Blood 2006, 108:2095-2105.
13. Chan K.M., Bonde S., Klump H., Zavazava N. Hematopoiesis and immunity of HOXB4-transduced embryonic stem cell-derived hematopoietic progenitor cells. Blood 2008, 111:2953-2961.
14. Kyba M., Perlingeiro R.C., Daley G.Q. HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk-sac hematopoietic progenitors. Cell 2002, 109:29-37.
15. Zhu M.X., Zhao J.Y., Chen G.A. Mesoderm is committed to hemato-endothelial and cardiac lineage in human embryoid bodies by sequential exposure to cytokines. Exp. Cell Res. 2013, 319:21-34.
16. Holmes R., Zúñiga-Pflücker J.C. The OP9-DL1 system: generation of T-lymphocytes from embryonic or hematopoietic stem cells in vitro. Cold Spring Harb. Protoc. 2009, 4:1-12.
17. de Pooter R., Zúñiga-Pflücker J.C. T-cell potential and development in vitro: the OP9-DL1 approach. Curr. Opin. Immunol. 2007, 19:163-168.
18. Awong G., La Motte-Mohs R.N., Zúñiga-Pflücker J.C. In vitro human T cell development directed by notch-ligand interactions. Methods Mol. Biol. 2008, 430:135-142.
19. Schmitt T.M., de Pooter R.F., Gronski M.A., Cho S.K., Ohashi P.S., Zúñiga-Pflücker J.C. Induction of T cell development and establishment of T cell competence from embryonic stem cells differentiated in vitro. Nat. Immunol. 2004, 5:410-417.
20. Hirashima M., Kataoka H., Nishikawa S., Matsuyoshi N. Maturation of embryonic stem cells into endothelial cells in an in vitro model of vasculogenesis. Blood 1999, 93:1253-1263.
21. Gerecht-Nir S., Ziskind A., Cohen S., Itskovitz-Eldor J. Human embryonic stem cells as an in vitro model for human vascular development and the induction of vascular differentiation. Lab. Investig. 2003, 83:1811-1820.
22. Salvagiotto G., Burton S., Daigh C.A., Rajesh D., Slukvin I.I., Seay N.J. A defined, feeder-free, serum-free system to generate in vitro hematopoietic progenitors and differentiated blood cells from hESCs and hiPSCs. PloS One 2011, 6:e17829.
23. Kennedy M., Awong G., Sturgeon C.M., Ditadi A., LaMotte-Mohs R., Zúñiga-Pflücker J.C., Keller G. T lymphocyte potential marks the emergence of definitive hematopoietic progenitors in human pluripotent stem cell differentiation cultures. Cell Rep. 2012, 2:1722-1735.
24. Doulatov S., Notta F., Eppert K., Nguyen L.T., Ohashi P.S., Dick J.E. Revised map of the human progenitor hierarchy shows the origin of macrophages and dendritic cells in early lymphoid development. Nat. Immunol. 2010, 11:585-593.
25. Hao Q.L., George A.A., Zhu J., Barsky L., Zielinska E., Wang X., Price M., Ge S., Crooks G.M. Human intrathymic lineage commitment is marked by differential CD7 expression: identification of CD7-lympho-myeloid thymicprogentiors. Blood 2008, 111:1318-1326.
26. + cells in an in vitro thymicepithelia organ coculture model. Int. J. Immunopharmacol. 1999, 21:15-26.
27. Alvarez-Vallina L., Gonzalez A., Gambon F., Kreisler M., Diaz-Espada F. Delimitation of the proliferative stages in the human thymus indicates that cell expansion occurs before the expression of CD3 (T-cell receptor). J. Immunol. 1993, 150:8-16.
28. Fukuhara K., Okumura M., Shiono H., Inoue M., Kadota Y., Miyoshi S., Matsuda H. A study on CD45 isoform expression during T-cell development and selection events in the human thymus. Hum. Immunol. 2002, 63:394-404.
29. - cells, as well as macrophages. J. Immunol. 2001, 166:6593-6601.
30. Clark R.A., Yamanaka K., Bai M., Dowgiert R., Kupper T.S. Human skin cells support thymus-indipendent T cell development. J. Clin. Investig. 2005, 115:3239-3249.
31. Palamaro L., Guarino V., Scalia G., Antonini D., De Falco L., Bianchino G., Fusco A., Romano R., Grieco V., Missero C., Del Vecchio L., Ambrosio L., Pignata C. Human skin-derived keratinocytes and fibroblasts cocultured on 3D poly -caprolactone scaffold support in vitro HSCs differentiation into T-lineage committed cells. Int. Immunol. 2013, 25:703-714.
32. Meek B., Van Elssen C.H., Huijskens M.J., van der Stegen S.J., Tonnaer S., Lumeij S.B., Vanderlocht J., Kirkland M.A., Hessenlink R., Germeraad W.T., Bos G.M. T cells fail to develop in the human skin-cell explants system; an inconvenient truth. BMC Immunol. 2011, 12:17.
33. Ikawa T., Hirose S., Masuda K., Kakugawa K., Satoh R., Shibano-Satoh A., Kominami R., Katsura Y., Kawamoto H. An essential developmental checkpoint for production of the T cell lineage. Science 2010, 329:93-96.
34. Bigas A., Guiu J., Gama-Norton L. Notch and Wnt signaling in the emergence of hematopoietic stem cells. Blood Cells Mol. Dis. 2013, 51:264-270.
35. Peng Y., Chen Z., Yu W., Zhou Q., Xu.L., Mao F.F., Huang G., Zhang X., Li S., Lahn B.T., Xiang A.P. Effects of thymic polypeptides on the thymopoiesis of mouse embryonic stem cells. Cell Biol. Int. 2008, 32:1265-1271.